Biomarkers in Psychiatric Disorders
Central and peripheral biomarkers can be used to diagnose, treat, and potentially prevent major psychiatric disorders. But there is uncertainty about the role of these biological signatures in neural pathophysiology, and their clinical significance has yet to be firmly established. Psychomotor, cogn...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2022
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2022, Volume: 31, Issue: 4, Pages: 444-452 |
Further subjects: | B
Prevention
B Treatment B biomarkers B Prediction B Schizophrenia B Diagnosis B Psychiatry B Major Depressive Disorder |
Online Access: |
Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
LEADER | 00000naa a22000002 4500 | ||
---|---|---|---|
001 | 1827982527 | ||
003 | DE-627 | ||
005 | 20221220052655.0 | ||
007 | cr uuu---uuuuu | ||
008 | 221220s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1017/S0963180122000056 |2 doi | |
035 | |a (DE-627)1827982527 | ||
035 | |a (DE-599)KXP1827982527 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
084 | |a 1 |2 ssgn | ||
100 | 1 | |a Glannon, Walter |e VerfasserIn |4 aut | |
245 | 1 | 0 | |a Biomarkers in Psychiatric Disorders |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Central and peripheral biomarkers can be used to diagnose, treat, and potentially prevent major psychiatric disorders. But there is uncertainty about the role of these biological signatures in neural pathophysiology, and their clinical significance has yet to be firmly established. Psychomotor, cognitive, affective, and volitional impairment in these disorders results from the interaction between neural, immune, endocrine, and enteric systems, which in turn are influenced by a person’s interaction with the environment. Biomarkers may be a critical component of this process. The identification and interpretation of biomarkers also raise ethical and social questions. This article analyzes and discusses these aspects of biomarkers and how advances in biomarker research could contribute to personalized psychiatry that could prevent or mitigate the effects of these disorders. | ||
601 | |a Psychiatrie | ||
650 | 4 | |a Treatment | |
650 | 4 | |a Schizophrenia | |
650 | 4 | |a Psychiatry | |
650 | 4 | |a Prevention | |
650 | 4 | |a Prediction | |
650 | 4 | |a Major Depressive Disorder | |
650 | 4 | |a Diagnosis | |
650 | 4 | |a biomarkers | |
773 | 0 | 8 | |i Enthalten in |t Cambridge quarterly of healthcare ethics |d Cambridge : Cambridge Univ. Press, 1992 |g 31(2022), 4, Seite 444-452 |h Online-Ressource |w (DE-627)306655039 |w (DE-600)1499985-7 |w (DE-576)081985010 |x 1469-2147 |7 nnns |
773 | 1 | 8 | |g volume:31 |g year:2022 |g number:4 |g pages:444-452 |
856 | 4 | 0 | |u https://doi.org/10.1017/S0963180122000056 |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/biomarkers-in-psychiatric-disorders/D10686D6D08A5ECA03288CD34B38553D |x Verlag |z kostenfrei |3 Volltext |
935 | |a mteo | ||
936 | u | w | |d 31 |j 2022 |e 4 |h 444-452 |
951 | |a AR | ||
ELC | |a 1 | ||
ITA | |a 1 |t 1 | ||
LOK | |0 000 xxxxxcx a22 zn 4500 | ||
LOK | |0 001 423538743X | ||
LOK | |0 003 DE-627 | ||
LOK | |0 004 1827982527 | ||
LOK | |0 005 20221220052655 | ||
LOK | |0 008 221220||||||||||||||||ger||||||| | ||
LOK | |0 035 |a (DE-Tue135)IxTheo#2022-12-06#F0BAF712FCFCF448F6D11CC044FDCDBB314F7054 | ||
LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
LOK | |0 092 |o n | ||
LOK | |0 852 |a DE-Tue135 | ||
LOK | |0 852 1 |9 00 | ||
LOK | |0 935 |a ixzs |a ixrk |a zota | ||
OAS | |a 1 | ||
ORI | |a SA-MARC-ixtheoa001.raw |